Melanoma/Skin Cancer

Top Story

Adults with previous nonmelanoma skin cancer more likely to use sun protection, but still sunburn

May 25, 2016

While adults with previous nonmelanoma skin cancer were more likely to practice sun protection compared with people without a history of skin cancer, they reported similar relative odds of recent sunburn, according to published study results.

Researchers studied self-reported data from the 2005 and 2010 National Health Interview Surveys of non-Hispanic white adults, including 758 with previous nonmelanoma skin cancer (NMSC) and 34,161 without NMSC. Respondents were asked how long they stayed in the shade, wore a hat to shade their face, ears and neck, wore a long-sleeved shirt and if they used sunscreen while outside on a warm, sunny day for more than 1 hour.

Cover Story

Value in cancer care must ‘start with patients, not dollars’

HemOnc Today, May 25, 2016
The skyrocketing cost of cancer care has come under intense criticism from patients and health care providers.Several promising treatments — including traditional…
Meeting News Coverage

Nivolumab–ipilimumab combination should be considered standard of care

HemOnc Today, May 25, 2016
Editor’s Note: Results of the randomized phase 2 CheckMate 069 trial showed the addition of nivolumab (Opdivo, Bristol-Myers Squibb) to ipilimumab (Yervoy
In the Journals

Lower vitamin D levels associated with worse outcomes in melanoma

May 23, 2016
Lower levels of vitamin D correlated with poorer outcomes in patients with melanoma, according to prospective study results.Prior research showed elevated
CME

The Patient with Castration-resistant Prostate Cancer

No commercial support for this activity.

Castration-resistant prostate cancer (CRPC) is a heterogeneous condition that encompasses a continuum of disease…
More »
Video
Meeting News Coverage

VIDEO: Melanoma research must determine how to maximize efficacy, minimize toxicity

April 17, 2016
More »
Featured
AACR Annual Meeting

AACR Annual Meeting

CME

The Patient with Myelofibrosis

No commercial support for this activity.

Myelofibrosis is caused by abnormal stem cells in the bone marrow that cause the uncontrolled production of mature…
More »
In the Journals

Adults with previous nonmelanoma skin cancer more likely to use sun protection, but still sunburn

May 25, 2016
While adults with previous nonmelanoma skin cancer were more likely to practice sun protection compared with people without a history of skin cancer…

Cover Story

Value in cancer care must ‘start with patients, not dollars’

HemOnc Today, May 25, 2016
The skyrocketing cost of cancer care has come under intense criticism from patients and health care providers.Several promising treatments —…

Meeting News Coverage

Nivolumab–ipilimumab combination should be considered standard of care

HemOnc Today, May 25, 2016
Editor’s Note: Results of the randomized phase 2 CheckMate 069 trial showed the addition of nivolumab (Opdivo, Bristol-Myers Squibb) to

In the Journals

Lower vitamin D levels associated with worse outcomes in melanoma

May 23, 2016
Lower levels of vitamin D correlated with poorer outcomes in patients with melanoma, according to prospective study results.Prior research showed…

‘Surge’ in unnecessary CT scans significantly increases cancer risks

May 23, 2016
A single standard CT scan may increase the risk for fatal cancer in one of every 2,000 patients, according to FDA data.Repeat or excessive exposure…

Meeting News Coverage

Sleep apnea linked to greater melanoma aggressiveness

May 20, 2016
Increased aggressiveness of malignant cutaneous melanoma is associated with untreated severe obstructive sleep apnea, according to a study presented…

Meeting News CoveragePerspective

Pembrolizumab improves long-term outcomes for patients with advanced melanoma

May 19, 2016
Forty percent of patients with advanced melanoma achieved 3-year OS with pembrolizumab, according to long-term follow-up of the KEYNOTE-001 study…

Meeting News CoveragePerspective

Precision medicine approach improves outcomes in phase 1 trials

May 19, 2016
Patients treated in phase 1 trials designed with a biomarker-based approach for treatment selection demonstrated higher response rates and longer…

Congressional subcommittee debates Medicare Part B demonstration project

May 17, 2016
The U.S. House Energy Subcommittee on Health today held a hearing to offer doctor and patient perspectives on planned changes to the Medicare Part B…

At IssueVideo

VIDEO: Emerging data on checkpoint blockades suggest potential ‘cure’ for certain tumors, not all cancer

May 16, 2016
James P. Allison, PhD, chair of the department of immunology and executive director of the immunotherapy platform at the MD Anderson Cancer Center in…

More Headlines »
morganatic-roan